Literature DB >> 1970484

Restriction fragment length polymorphism of the L-myc gene in oral cancer patients.

D Saranath1, R G Panchal, R Nair, A R Mehta, V Sanghavi, M G Deo.   

Abstract

Restriction fragment length polymorphism (RFLP) of the L-myc gene was examined in DNAs from primary tumour tissues and peripheral blood cells (PBC) of 76 Indian patients with squamous cell carcinoma of the oral cavity, and PBC from 101 normal healthy volunteers. The patients and the normal healthy volunteers were classified into three genetic types according to the polymorphic patterns defined by the two alleles (6.6 kb, S fragment; and 10.0 kb, L fragment). DNA isolated from the PBC of each patient always exhibited the same pattern of L-myc alleles as that observed for the corresponding tumour DNA. However, a striking correlation was found between the RFLP pattern and the stage of differentiation of the tumours, as well as the size of the tumour. Thus, a preponderance of the S fragment was observed in the poor to moderately differentiated tumours and the larger (greater than 4 cm) sized tumours. Further, analysis of L-myc RFLP with the clinical pattern of the malignancy showed no significant correlation with nodal metastasis, TNM staging or recurrence of the tumour. The relative ratios of the three genotypes (L-L, L-S, S-S) in the oral cancer patients were not significantly different from those seen in the healthy Indians, implying no predisposition to oral cancer by either allele. However, our results showed that oral cancer patients with a genotype including an S fragment are more likely to develop a poor to moderately differentiated tumour or a larger tumour than a patient without an S fragment. The L and S alleles were equally distributed in the population, with the frequency of each allele being 0.50, consistent with Hardy-Weinberg's law.

Entities:  

Mesh:

Year:  1990        PMID: 1970484      PMCID: PMC1971348          DOI: 10.1038/bjc.1990.119

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  17 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

Review 2.  Restriction fragment length polymorphism and activation of c-Ha-ras gene in urothelial cancer.

Authors:  J Ishikawa; S Maeda; S Kamidono; T Sugiyama
Journal:  Anticancer Res       Date:  1988 Sep-Oct       Impact factor: 2.480

3.  Unique allelic restriction fragments of the human Ha-ras locus in leukocyte and tumour DNAs of cancer patients.

Authors:  T G Krontiris; N A DiMartino; M Colb; D R Parkinson
Journal:  Nature       Date:  1985 Jan 31-Feb 6       Impact factor: 49.962

4.  Evaluation of cancer risk in tobacco chewers and smokers: an epidemiologic assessment.

Authors:  D J Jussawalla; V A Deshpande
Journal:  Cancer       Date:  1971-07       Impact factor: 6.860

5.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

6.  Restriction fragment length polymorphism of the L-myc gene and susceptibility to metastasis in renal cancer patients.

Authors:  Y Kakehi; O Yoshida
Journal:  Int J Cancer       Date:  1989-03-15       Impact factor: 7.396

Review 7.  Construction of a genetic linkage map in man using restriction fragment length polymorphisms.

Authors:  D Botstein; R L White; M Skolnick; R W Davis
Journal:  Am J Hum Genet       Date:  1980-05       Impact factor: 11.025

8.  Control of oral cancer in developing countries. A WHO meeting.

Authors: 
Journal:  Bull World Health Organ       Date:  1984       Impact factor: 9.408

9.  Presence of an allelic EcoRI restriction fragment of the c-mos locus in leukocyte and tumor cell DNAs of breast cancer patients.

Authors:  R Lidereau; D Mathieu-Mahul; C Theillet; M Renaud; M Mauchauffé; J Gest; C J Larsen
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

10.  Genetic predisposition to human lung cancer.

Authors:  J Heighway; N Thatcher; T Cerny; P S Hasleton
Journal:  Br J Cancer       Date:  1986-04       Impact factor: 7.640

View more
  7 in total

1.  Changes in expression of oncogenes and TP53 tumour suppressor gene as biomarkers in head and neck cancers.

Authors:  István Szanyi; Miklós Bauer; Imre Gerlinger; Tamás Járai; Gyula Gobel; László Lujber; Eva Szabadi; Katalin Fehér; Agoston Émber; István Ember; István Kiss
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-12-01       Impact factor: 2.503

2.  Loss of allelic heterozygosity at the harvey ras locus in human oral carcinomas.

Authors:  D Saranath; L T Bhoite; A R Mehta; V Sanghavi; M G Deo
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

Review 3.  Biologic markers, cellular differentiation, and metastatic head and neck cancer.

Authors:  S P Schantz
Journal:  Eur Arch Otorhinolaryngol       Date:  1993       Impact factor: 2.503

4.  High frequency mutation in codons 12 and 61 of H-ras oncogene in chewing tobacco-related human oral carcinoma in India.

Authors:  D Saranath; S E Chang; L T Bhoite; R G Panchal; I B Kerr; A R Mehta; N W Johnson; M G Deo
Journal:  Br J Cancer       Date:  1991-04       Impact factor: 7.640

5.  MYCL genotypes and loss of heterozygosity in non-small-cell lung cancer.

Authors:  K M Fong; Y Kida; P V Zimmerman; P J Smith
Journal:  Br J Cancer       Date:  1996-12       Impact factor: 7.640

6.  Different susceptibility of each L-myc genotype to esophageal cancer risk factors.

Authors:  H Kumimoto; N Hamajima; K Nishizawa; Y Nishimoto; K Matsuo; H Harada; M Shinoda; S Hatooka; K Ishizaki
Journal:  Jpn J Cancer Res       Date:  2001-07

7.  Increased frequency of the S allele of the L-myc oncogene in non-Hodgkin's lymphoma.

Authors:  P E Crossen; M J Morrison; B M Colls
Journal:  Br J Cancer       Date:  1994-04       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.